Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living with HIV-1
2023-507173-18-00Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing VH4524184 with Placebo (2 arms). Primary endpoint: Maximum Change from Baseline in log10 Plasma HIV-1 RNA Through Day 10. Started Apr 2024; status: completed.
02
Drugs
VH4524184
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2023-507173-18-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507173-18-00.